WRIGHT STATE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1964-01-01

Employees: 1.9K

Market Cap: -

Website: http://www.wright.edu

Clinical Trials

Efficacy and Safety of Salkera Emollient Foam in the Treatment of Moderate to Severe Keratosis Pilaris, a Prospective Study

Phase 4

Terminated

Conditions: Keratosis Pilaris

Interventions: Drug: Salkera Emollient Foam

First Posted Date: 2009-07-23

Last Posted Date: 2022-02-04

Lead Sponsor: Wright State University

Target Recruit Count: 1

Registration Number: NCT00944216

Locations: 🇺🇸
Wright State University School of Medicine, Department of Dermatology, Dayton, Ohio, United States

Safety Trial of Single Versus Multiple Dose Thymoglobulin Induction in Kidney Transplantation

Phase 2

Completed

Conditions: End-Stage Renal Disease
Kidney Failure

Interventions: Biological: Single-dose rabbit Anti-thymocyte Globulin induction
Biological: Divided-dose rabbit Anti-thymocyte Globulin induction

First Posted Date: 2009-05-21

Last Posted Date: 2015-12-07

Lead Sponsor: Wright State University

Target Recruit Count: 99

Registration Number: NCT00906204

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States
🇺🇸
Wake Forest University, Winston-Salem, North Carolina, United States
🇺🇸
The Methodist Hospital Research Institute, Houston, Texas, United States

and more 1 locations

Efficacy Study of Humira in the Treatment of Cutaneous Sarcoidosis

Phase 2

Withdrawn

Conditions: Sarcoidosis
Cutaneous Sarcoidosis

Interventions: Drug: Humira

First Posted Date: 2008-08-11

Last Posted Date: 2022-02-15

Lead Sponsor: Wright State University

Registration Number: NCT00731757

Locations: 🇺🇸
Stanford University, Stanford, California, United States

Safety and Efficacy Study of Humira in Treatment of Pyoderma Gangrenosum

Phase 2

Withdrawn

Conditions: Pyoderma Gangrenosum

Interventions: Drug: Humira

First Posted Date: 2008-08-08

Last Posted Date: 2022-02-15

Lead Sponsor: Wright State University

Registration Number: NCT00730717

Locations: 🇺🇸
Stanford University, Stanford, California, United States

Reducing Barriers to Drug Abuse Treatment Services

Phase 2

Completed

Conditions: Substance Abuse

Interventions: Behavioral: Motivational interviewing
Behavioral: Strengths-Based Case Management

First Posted Date: 2006-01-09

Last Posted Date: 2009-02-24

Lead Sponsor: Wright State University

Target Recruit Count: 678

Registration Number: NCT00273845

Locations: 🇺🇸
Samaritan CrisisCare, Dayton, Ohio, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy